化学干预应对阿片类药物危机：主要进展和遗留挑战。
Chemical Interventions for the Opioid Crisis: Key Advances and Remaining Challenges.
机构信息
Department of Chemistry, Department of Immunology and Microbial Science, The Skaggs Institute for Chemical Biology, and WIRM Institute for Research and Medicine , The Scripps Research Institute , La Jolla , California 92037 , United States.
出版信息
J Am Chem Soc. 2019 Feb 6;141(5):1798-1806. doi: 10.1021/jacs.8b09756. Epub 2018 Dec 11.
Abstract
The present United States opioid crisis requires urgent and innovative scientific intervention. This perspective highlights a role for the chemical sciences by expounding upon three key research areas identified as priorities by the National Institute on Drug Abuse (NIDA). Specifically, important advances in chemical interventions for overdose reversal, strategies for opioid use disorder (OUD) treatment, including immunopharmacotherapies, and next-generation alternatives for pain management will be discussed. Ultimately, progress made will be presented in light of remaining challenges for the field.
摘要
目前美国的阿片类药物危机需要紧急和创新的科学干预。本观点通过阐述国家药物滥用研究所（NIDA）确定的三个优先重点研究领域，强调了化学科学的作用。具体而言，将讨论用于逆转过量用药的化学干预、阿片类药物使用障碍（OUD）治疗策略（包括免疫药理学疗法）以及用于疼痛管理的下一代替代方案方面的重要进展。最终，将根据该领域的剩余挑战来呈现取得的进展。
相似文献
1
Chemical Interventions for the Opioid Crisis: Key Advances and Remaining Challenges.化学干预应对阿片类药物危机：主要进展和遗留挑战。
J Am Chem Soc. 2019 Feb 6;141(5):1798-1806. doi: 10.1021/jacs.8b09756. Epub 2018 Dec 11.
2
NIDA's medication development priorities in response to the Opioid Crisis: ten most wanted.美国国家药物滥用研究所应对阿片类药物危机的药物研发重点：十大急需药物。
Neuropsychopharmacology. 2019 Mar;44(4):657-659. doi: 10.1038/s41386-018-0292-5. Epub 2018 Dec 7.
3
Improving treatment for opioid dependence: a perspective from the Ohio Valley node of the NIDA Clinical Trials Network.改善阿片类药物依赖的治疗：来自美国国立药物滥用研究所临床试验网络俄亥俄谷节点的观点。
Prog Community Health Partnersh. 2014 Spring;8(1):99-107. doi: 10.1353/cpr.2014.0002.
4
U.S. Military veterans and the opioid overdose crisis: a review of risk factors and prevention efforts.美国退伍军人与阿片类药物过量危机：风险因素和预防工作的回顾。
Ann Med. 2022 Dec;54(1):1826-1838. doi: 10.1080/07853890.2022.2092896.
5
National Institute on Drug Abuse International Program: improving opioid use disorder treatment through international research training.国家药物滥用研究所国际项目：通过国际研究培训改善阿片类药物使用障碍治疗。
Curr Opin Psychiatry. 2018 Jul;31(4):287-293. doi: 10.1097/YCO.0000000000000426.
6
Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.开发阿片类药物使用障碍的临床决策支持：NIDA 临床试验网络工作组报告。
Addict Sci Clin Pract. 2020 Jan 16;15(1):4. doi: 10.1186/s13722-020-0180-2.
7
Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.监禁人员中与阿片类药物相关的治疗、干预措施和结果：系统评价。
PLoS Med. 2019 Dec 31;16(12):e1003002. doi: 10.1371/journal.pmed.1003002. eCollection 2019 Dec.
8
Promoting opioid overdose prevention and recovery: An exploratory study of an innovative intervention model to address opioid abuse.促进阿片类药物过量预防和康复：探索性研究一种创新的干预模式，以解决阿片类药物滥用问题。
Int J Drug Policy. 2019 Feb;64:21-29. doi: 10.1016/j.drugpo.2018.12.004. Epub 2018 Dec 12.
9
HEAL Preventing Opioid Use Disorder: a Vision for Research to Increase Access to Prevention Services.预防阿片类药物使用障碍：增加预防服务可及性的研究愿景。
Prev Sci. 2023 Oct;24(Suppl 1):8-15. doi: 10.1007/s11121-023-01547-9. Epub 2023 Aug 21.
10
Physician Perspective and Challenges Ordering/Interpreting Laboratory Tests Related to the Opioid Crisis in America.医生视角与挑战：美国阿片类药物危机相关的实验室检测开单/解读。
Ther Drug Monit. 2021 Feb 1;43(1):6-13. doi: 10.1097/FTD.0000000000000840.
引用本文的文献
1
High-Throughput Drug Derivatization and Bioassay by Desorption Electrospray Ionization Mass Spectrometry.基于解吸电喷雾电离质谱的高通量药物衍生化及生物测定
Chempluschem. 2025 Jun;90(6):e202500164. doi: 10.1002/cplu.202500164. Epub 2025 Apr 30.
2
Opioid-Based Haptens: Development of Immunotherapy.基于阿片类药物的半抗原：免疫疗法的发展。
Int J Mol Sci. 2024 Jul 16;25(14):7781. doi: 10.3390/ijms25147781.
3
Blocking potential metabolic sites on NAT to improve its safety profile while retaining the pharmacological profile.阻断 NAT 上的潜在代谢位点，在保留药理学特征的同时提高其安全性。
Bioorg Chem. 2024 Jul;148:107489. doi: 10.1016/j.bioorg.2024.107489. Epub 2024 May 22.
4
Enantioselective synthesis of 14-hydroxy-6-oxomorphinans.对映选择性合成 14-羟基-6-氧代吗啡烷。
Chem Commun (Camb). 2024 Jun 6;60(47):6007-6010. doi: 10.1039/d4cc01788a.
5
Gain-of-function and loss-of-function variants in GRIA3 lead to distinct neurodevelopmental phenotypes.GRIA3基因的功能获得性和功能丧失性变异导致不同的神经发育表型。
Brain. 2024 May 3;147(5):1837-1855. doi: 10.1093/brain/awad403.
6
Development of a vaccine against the synthetic opioid U-47700.针对合成阿片类药物U-47700的疫苗研发。
Front Pharmacol. 2023 Jul 10;14:1219985. doi: 10.3389/fphar.2023.1219985. eCollection 2023.
7
Inhibitory Effects of a Novel μ-Opioid Receptor Nonpeptide Antagonist, UD-030, on Morphine-Induced Conditioned Place Preference.新型 μ 阿片受体非肽拮抗剂 UD-030 对吗啡诱导的条件性位置偏爱反应的抑制作用。
Int J Mol Sci. 2023 Feb 8;24(4):3351. doi: 10.3390/ijms24043351.
8
Synthesis of New Morphinan Opioids by TBADT-Catalyzed Photochemical Functionalization at the Carbon Skeleton.通过 TBADT 催化的碳骨架光化学功能化合成新型吗啡烷类阿片样物质。
Chemistry. 2022 Sep 6;28(50):e202201478. doi: 10.1002/chem.202201478. Epub 2022 Jul 13.
9
A Highly Efficacious Carfentanil Vaccine That Blunts Opioid-Induced Antinociception and Respiratory Depression.一种高效的卡芬太尼疫苗，可减轻阿片类药物引起的抗伤害感受和呼吸抑制。
ACS Chem Biol. 2021 Feb 19;16(2):277-282. doi: 10.1021/acschembio.1c00026. Epub 2021 Feb 3.
10
Supramolecular hosts as in vivo sequestration agents for pharmaceuticals and toxins.超分子主体作为药物和毒素的体内螯合剂。
Chem Soc Rev. 2020 Nov 7;49(21):7516-7532. doi: 10.1039/d0cs00454e. Epub 2020 Oct 12.
本文引用的文献
1
Efficacious Vaccine against Heroin Contaminated with Fentanyl.有效对抗海洛因芬太尼污染的疫苗。
ACS Chem Neurosci. 2018 Jun 20;9(6):1269-1275. doi: 10.1021/acschemneuro.8b00079. Epub 2018 Mar 23.
2
Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses - United States, July 2016-September 2017.生命体征：2016年7月至2017年9月美国疑似阿片类药物过量急诊就诊趋势
MMWR Morb Mortal Wkly Rep. 2018 Mar 9;67(9):279-285. doi: 10.15585/mmwr.mm6709e1.
3
A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse.一种稳定的海洛因类似物，可用作疫苗半抗原，诱导抗体，阻断海洛因及其代谢物在啮齿动物中的作用，并与相关滥用药物发生免疫交叉反应。
J Med Chem. 2018 Jan 11;61(1):329-343. doi: 10.1021/acs.jmedchem.7b01427. Epub 2017 Dec 29.
4
A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (μ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty.一项随机IIb期研究，旨在调查oliceridine（TRV130），一种新型μ受体G蛋白途径选择性（μ-GPS）调节剂，用于腹部整形术后中度至重度急性疼痛的管理。
J Pain Res. 2017 Oct 6;10:2413-2424. doi: 10.2147/JPR.S137952. eCollection 2017.
5
Conjugate Vaccine Immunotherapy for Substance Use Disorder.用于物质使用障碍的共轭疫苗免疫疗法。
Pharmacol Rev. 2017 Jul;69(3):298-315. doi: 10.1124/pr.117.013904.
6
Development of a Clinically Viable Heroin Vaccine.开发一种临床上可行的海洛因疫苗。
J Am Chem Soc. 2017 Jun 28;139(25):8601-8611. doi: 10.1021/jacs.7b03334. Epub 2017 Jun 20.
7
The Role of Science in Addressing the Opioid Crisis.科学在应对阿片类药物危机中的作用。
N Engl J Med. 2017 Jul 27;377(4):391-394. doi: 10.1056/NEJMsr1706626. Epub 2017 May 31.
8
A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal.一项关于洛非西定缓解住院阿片类药物戒断患者症状的安全性和有效性的III期、随机、多中心、双盲、安慰剂对照研究。
Drug Alcohol Depend. 2017 Jul 1;176:79-88. doi: 10.1016/j.drugalcdep.2017.02.020. Epub 2017 May 10.
9
Addressing the Fentanyl Threat to Public Health.应对芬太尼对公众健康的威胁。
N Engl J Med. 2017 Feb 16;376(7):605-607. doi: 10.1056/NEJMp1615145.
10
Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats.氯卡色林抑制大鼠对羟考酮的自我给药及复吸易感性。
ACS Chem Neurosci. 2017 May 17;8(5):1065-1073. doi: 10.1021/acschemneuro.6b00413. Epub 2017 Feb 13.
Zotero 插件